Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    19706583 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Withdrawn Timolol Option for Ulcerated Hemangiomas (TOUCH Trial)
Condition: Infantile Hemangiomas
Interventions: Drug: Timolol 0.5% Gel Forming Solution (GFS);   Drug: Mupirocin 2% Ointment
2 Completed
Has Results
Study to Demonstrate the Efficacy and Safety of Propranolol Oral Solution in Infants With Proliferating Infantile Hemangiomas Requiring Systemic Therapy
Condition: Infantile Hemangioma
Interventions: Drug: Propranolol;   Drug: Placebo
3 Recruiting Sildenafil for the Treatment of Lymphatic Malformations
Conditions: Lymphatic Malformations;   Lymphatic Diseases
Interventions: Drug: Sildenafil 20 mg tablets;   Other: Placebo tablets (resembling Revatio)

Indicates status has not been verified in more than two years